Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 18020
Country/Region: Lesotho
Year: 2016
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $9,030,719 Additional Pipeline Funding: $1,084,388

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $586,159
Care: TB/HIV (HVTB) $1,366,850
Care: Pediatric Care and Support (PDCS) $598,009
Testing: HIV Testing and Counseling (HVCT) $475,818
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $312,695
Treatment: Adult Treatment (HTXS) $4,694,038
Treatment: Pediatric Treatment (PDTX) $997,150
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 13,396
HTS_TST Age/sex: 1-9 2017 32,479
HTS_TST Age/sex: 10-14 Female 2017 10,780
HTS_TST Age/sex: 10-14 Male 2017 10,754
HTS_TST Age/sex: 15-19 Female 2017 10,547
HTS_TST Age/sex: 15-19 Male 2017 6,968
HTS_TST Age/sex: 20-24 Female 2017 8,784
HTS_TST Age/sex: 20-24 Male 2017 5,889
HTS_TST Age/sex: 25-49 Female 2017 88,026
HTS_TST Age/sex: 25-49 Male 2017 58,649
HTS_TST Age/sex: 50+ Female 2017 55,113
HTS_TST Age/sex: 50+ Male 2017 32,584
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 38,315
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 29,110
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 162,454
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 104,092
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 333,969
HTS_TST Service Delivery Point (Facility): Inpatient 2017 2,344
HTS_TST Service Delivery Point (Facility): Other PITC 2017 17,780
HTS_TST Service Delivery Point (Facility): Outpatient 2017 197,114
HTS_TST Service Delivery Point (Facility): PMTCT 2017 95,401
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 32,317
HTS_TST Sum of Age/Sex disaggregates 2017 288,094
HTS_TST Sum of Aggregated Age/Sex <15 2017 67,425
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 266,546
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 333,971
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 812
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 803
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 887
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 583
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 1,386
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 910
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 18,366
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 12,304
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 5,714
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 3,386
HTS_TST_POS Test Result by Age: Positive: <1 2017 397
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 1,991
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 2,236
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 1,753
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 26,366
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 17,183
PMTCT_ART Already on ART at beginning of current pregnancy 2017 2,104
PMTCT_ART New on ART 2017 3,253
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 19,693
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 3,802
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 1,475
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 19
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 43
PMTCT_EID Sum of Infant Age disaggregates 2017 5,277
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 120
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 5,120
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 6,184
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 8,254
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 15
PMTCT_STAT By: Known positives at entry 2017 3,410
PMTCT_STAT By: Number of new positives identified 2017 2,228
PMTCT_STAT Number of new ANC and L&D clients 2017 20,880
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 19,693
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 17
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 876
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 1,017
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 1,496
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 1
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 13
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 524
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 732
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 960
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 2
PMTCT_STAT Sum of Positives Status disaggregates 2017 5,638
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 166
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 5,438
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 6,576
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 8,692
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 8
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 130
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2,386
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 153
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3,226
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 5,895
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 5,895
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 3,969
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 3,969
TB_SCREENDX Screen Result: Screened Positive for TB 2017 3,969
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 58,220
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 31,354
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 2,355
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 2,355
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 94,284
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 209
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3,529
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 257
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 4,760
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 8,755
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 8,755
TX_CURR Age/Sex: <1 2017 570
TX_CURR Age/Sex: <1-9 2017 2,877
TX_CURR Age/Sex: 10-14 Female 2017 1,156
TX_CURR Age/Sex: 10-14 Male 2017 1,149
TX_CURR Age/Sex: 15-19 Female 2017 2,078
TX_CURR Age/Sex: 15-19 Male 2017 1,387
TX_CURR Age/Sex: 20-24 Female 2017 3,462
TX_CURR Age/Sex: 20-24 Male 2017 2,307
TX_CURR Age/Sex: 25-49 Female 2017 46,374
TX_CURR Age/Sex: 25-49 Male 2017 30,931
TX_CURR Age/Sex: 50+ Female 2017 14,548
TX_CURR Age/Sex: 50+ Male 2017 8,565
TX_CURR Aggregated Age/Sex: <15 Female 2017 2,877
TX_CURR Aggregated Age/Sex: <15 Male 2017 2,874
TX_CURR Aggregated Age/Sex: 15+ Female 2017 66,467
TX_CURR Aggregated Age/Sex: 15+ Male 2017 43,186
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 115,404
TX_CURR Sum of age/sex disaggregates 2017 3,465
TX_CURR Sum of Aggregated Age/Sex <15 2017 5,751
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 109,653
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 115,404
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 1,355
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 1,355
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 31,483
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 20,479
TX_NEW By Age/Sex: <1 2017 272
TX_NEW By Age/Sex: 1-9 2017 1,365
TX_NEW By Age/Sex: 10-14 Female 2017 546
TX_NEW By Age/Sex: 10-14 Male 2017 546
TX_NEW By Age/Sex: 15-19 Female 2017 984
TX_NEW By Age/Sex: 15-19 Male 2017 655
TX_NEW By Age/Sex: 20-24 Female 2017 1,640
TX_NEW By Age/Sex: 20-24 Male 2017 1,088
TX_NEW By Age/Sex: 25-49 Female 2017 21,965
TX_NEW By Age/Sex: 25-49 Male 2017 14,653
TX_NEW By Age/Sex: 50+ Female 2017 6,885
TX_NEW By Age/Sex: 50+ Male 2017 4,070
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 54,672
TX_NEW Sum of Age/Sex disaggregates 2017 53,032
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 54,672
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 92,275
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 82,958
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 2,068
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 2,069
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 47,776
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 31,033
TX_PVLS Numerator: Indication: Routine 2017 82,958
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 2,319
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 2,319
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 53,450
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 34,187
TX_PVLS_den Denominator: Indication: Routine 2017 92,275
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 347
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 694
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 347
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 350
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,211
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 190
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,626
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 585
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 14,389
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8,794
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,092
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,490
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 865
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 871
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 22,302
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 11,075
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 35,115
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 42,792
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 425
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 847
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 424
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 431
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,467
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 239
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,409
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 715
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 17,520
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 10,727
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,772
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,816
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,062
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,062
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 27,174
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 13,494
Cross Cutting Budget Categories and Known Amounts Total: $2,209,000
Human Resources for Health $1,614,000
Food and Nutrition: Policy, Tools, and Service Delivery $200,000
Motor Vehicles: Purchased $150,000
Gender: Gender Equality $30,000
GBV Prevention
Increase gender-equitable access to income and productive resources, including education
Gender: Gender Based Violence (GBV) $15,000
Post GBV Care
Water $200,000